Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach


Dateien zu dieser Ressource

Prüfsumme: MD5:8506098a8e8d8f88c343c27ec1dd3547

CHEN, Frances S., Robert KUMSTA, Fabian DVORAK, Gregor DOMES, O. S. YIM, Richard P. EBSTEIN, Markus HEINRICHS, 2015. Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach. In: Translational Psychiatry. 5(10), e664. eISSN 2158-3188. Available under: doi: 10.1038/tp.2015.163

@article{Chen2015Genet-33432, title={Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach}, year={2015}, doi={10.1038/tp.2015.163}, number={10}, volume={5}, journal={Translational Psychiatry}, author={Chen, Frances S. and Kumsta, Robert and Dvorak, Fabian and Domes, Gregor and Yim, O. S. and Ebstein, Richard P. and Heinrichs, Markus}, note={Article Number: e664} }

<rdf:RDF xmlns:dcterms="" xmlns:dc="" xmlns:rdf="" xmlns:bibo="" xmlns:dspace="" xmlns:foaf="" xmlns:void="" xmlns:xsd="" > <rdf:Description rdf:about=""> <dc:date rdf:datatype="">2016-03-23T13:40:32Z</dc:date> <dc:contributor>Ebstein, Richard P.</dc:contributor> <dcterms:abstract xml:lang="eng">Intranasal administration of the neuropeptide oxytocin has been shown to influence a range of complex social cognitions and social behaviors, and it holds therapeutic potential for the treatment of mental disorders characterized by social functioning deficits such as autism, social phobia and borderline personality disorder. However, considerable variability exists in individual responses to oxytocin administration. Here, we undertook a study to investigate the role of genetic variation in sensitivity to exogenous oxytocin using a socioemotional task. In a randomized, double-blind, placebo-controlled experiment with a repeated-measures (crossover) design, we assessed the performance of 203 men on an emotion recognition task under oxytocin and placebo. We took a haplotype-based approach to investigate the association between oxytocin receptor gene variation and oxytocin sensitivity. We identified a six-marker haplotype block spanning the promoter region and intron 3 that was significantly associated with our measure of oxytocin sensitivity. Specifically, the TTCGGG haplotype comprising single-nucleotide polymorphisms rs237917-rs2268498-rs4564970-rs237897-rs2268495-rs53576 is associated with increased emotion recognition performance under oxytocin versus placebo, and the CCGAGA haplotype with the opposite pattern. These results on the genetic modulation of sensitivity to oxytocin document a significant source of individual differences with implications for personalized treatment approaches using oxytocin administration.</dcterms:abstract> <dc:creator>Ebstein, Richard P.</dc:creator> <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/> <foaf:homepage rdf:resource="http://localhost:8080/jspui"/> <dcterms:rights rdf:resource=""/> <dcterms:issued>2015</dcterms:issued> <dcterms:title>Genetic modulation of oxytocin sensitivity : a pharmacogenetic approach</dcterms:title> <dcterms:hasPart rdf:resource=""/> <dc:contributor>Kumsta, Robert</dc:contributor> <dc:contributor>Chen, Frances S.</dc:contributor> <dcterms:isPartOf rdf:resource=""/> <dspace:hasBitstream rdf:resource=""/> <dc:creator>Heinrichs, Markus</dc:creator> <dc:rights>terms-of-use</dc:rights> <dc:creator>Yim, O. S.</dc:creator> <dc:language>eng</dc:language> <dc:creator>Domes, Gregor</dc:creator> <dspace:isPartOfCollection rdf:resource=""/> <bibo:uri rdf:resource=""/> <dc:creator>Dvorak, Fabian</dc:creator> <dcterms:available rdf:datatype="">2016-03-23T13:40:32Z</dcterms:available> <dc:contributor>Yim, O. S.</dc:contributor> <dc:contributor>Dvorak, Fabian</dc:contributor> <dc:contributor>Domes, Gregor</dc:contributor> <dc:creator>Kumsta, Robert</dc:creator> <dc:creator>Chen, Frances S.</dc:creator> <dc:contributor>Heinrichs, Markus</dc:contributor> </rdf:Description> </rdf:RDF>

Dateiabrufe seit 23.03.2016 (Informationen über die Zugriffsstatistik)

Chen_0-319842.pdf 167

Das Dokument erscheint in:

KOPS Suche


Mein Benutzerkonto